Palvella Therapeutics raises $9.7M to advance drug candidate targeting multiple rare diseases

The company's lead experimental drug is being tested as a treatment for three different rare diseases, with more on the horizon.

Source: bizjournals.com Health Care News Headlines - January 6, 2023 Category: Health Management Authors: John George Source Type: news